TY  - GEN
AU  - Jeong,Young-Hoon
AU  - Kim,In-Suk
AU  - Park,Yongwhi
AU  - Kang,Min-Kyung
AU  - Koh,Jin-Sin
AU  - Hwang,Seok-Jae
AU  - Kwak,Choong Hwan
AU  - Hwang,Jin-Yong
TI  - Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study
SN  - 1876-7605
PY  - 2010///1108
KW  - ATP Binding Cassette Transporter, Subfamily B
KW  - ATP Binding Cassette Transporter, Subfamily B, Member 1
KW  - genetics
KW  - Aged
KW  - Angioplasty, Balloon, Coronary
KW  - adverse effects
KW  - Aryl Hydrocarbon Hydroxylases
KW  - Chi-Square Distribution
KW  - Clopidogrel
KW  - Cytochrome P-450 CYP2C19
KW  - Cytochrome P-450 CYP3A
KW  - Drug Resistance
KW  - Female
KW  - Gene Frequency
KW  - Genotype
KW  - Humans
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Phenotype
KW  - Platelet Activation
KW  - drug effects
KW  - Platelet Aggregation Inhibitors
KW  - administration & dosage
KW  - Platelet Function Tests
KW  - Polymorphism, Genetic
KW  - Registries
KW  - Republic of Korea
KW  - Risk Assessment
KW  - Risk Factors
KW  - Ticlopidine
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jcin.2010.05.007
ER  -